Patents by Inventor Thomas Battersby
Thomas Battersby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10808244Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: GrantFiled: March 21, 2019Date of Patent: October 20, 2020Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Publication number: 20190203202Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: ApplicationFiled: March 12, 2019Publication date: July 4, 2019Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Patent number: 10273473Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: GrantFiled: April 4, 2017Date of Patent: April 30, 2019Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Publication number: 20170247753Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: ApplicationFiled: April 4, 2017Publication date: August 31, 2017Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Patent number: 9719137Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: GrantFiled: June 29, 2016Date of Patent: August 1, 2017Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Patent number: 9695416Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: GrantFiled: July 18, 2013Date of Patent: July 4, 2017Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Publication number: 20160304951Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: ApplicationFiled: June 29, 2016Publication date: October 20, 2016Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Patent number: 9404154Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: GrantFiled: August 13, 2014Date of Patent: August 2, 2016Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Publication number: 20150152407Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.Type: ApplicationFiled: July 18, 2013Publication date: June 4, 2015Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
-
Publication number: 20140377755Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: ApplicationFiled: August 13, 2014Publication date: December 25, 2014Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Patent number: 8685646Abstract: The methods and reagents described herein can be used to shorten incubation times in hybridization assays. As demonstrated in the examples, we have identified specific sulfonic acid polymers and hybridization conditions that lead to significantly shorter incubation times (e.g., signals after three hours that are comparable to signals that could traditionally only be obtained after overnight incubation). In some embodiments, shorter incubation times are achieved by adding the sulfonic acid polymer(s) during the hybridization process. Alternatively or additionally, in some embodiments, shorter incubation times are achieved via changes to the hybridizing conditions, e.g., by reducing the hybridization volume, increasing the salt concentration, andor increasing the probe concentration (capture extender probe andor label extender probe).Type: GrantFiled: December 18, 2009Date of Patent: April 1, 2014Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Mark Baumeister, Jesse Brooks, Felix Kleshik, Stacey Tam
-
Patent number: 8399194Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.Type: GrantFiled: December 21, 2007Date of Patent: March 19, 2013Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Maria Albalos, Thomas Battersby, Edward Brooks, Michel Friesenhahn
-
Publication number: 20120142004Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: ApplicationFiled: May 19, 2010Publication date: June 7, 2012Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Publication number: 20110236997Abstract: The methods and reagents described herein can be used to shorten incubation times in hybridization assays. As demonstrated in the examples, we have identified specific sulfonic acid polymers and hybridization conditions that lead to significantly shorter incubation times (e.g., signals after three hours that are comparable to signals that could traditionally only be obtained after overnight incubation). In some embodiments, shorter incubation times are achieved by adding the sulfonic acid polymer(s) during the hybridization process. Alternatively or additionally, in some embodiments, shorter incubation times are achieved via changes to the hybridizing conditions, e.g., by reducing the hybridization volume, increasing the salt concentration, and/or increasing the probe concentration (capture extender probe and/or label extender probe).Type: ApplicationFiled: December 18, 2009Publication date: September 29, 2011Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Thomas Battersby, Mark Baumeister, Jesse Brooks, Felix Kleshik, Stacey Tam
-
Publication number: 20100190972Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.Type: ApplicationFiled: December 21, 2007Publication date: July 29, 2010Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Thomas Battersby, Maria Albalos, Michel Friesenhahn, Edward Brooks